REBECCA SMITH-SEALY: Open Payments
NPI 1346614591 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 29 payments from 9 companies in 2025. Trend: 2023 $832 · 2024 $892 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $161 |
| Incyte Corporation | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Janssen Biotech, Inc. | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| GENZYME CORPORATION | 3 | $54 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $22 |
| Organon LLC | 1 | $11 |
Products named: OTEZLA, DUPIXENT, OPZELURA, TREMFYA, Rhapsido, SKYRIZI, TALTZ, COSENTYX.
Industry payments across NM — which companies pay providers there.
